MSX-130
MSX-130 is a CXCR4 antagonist. MSX-130 inhibits cancer metastasis[1].
Product Specifications
CAS Number
[4051-59-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/msx-130.html
Purity
98.00
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C1(C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2)=CC=C(C5=NC(C6=CC=CC=C6)=C(C7=CC=CC=C7)N5)C=C1
Molecular Formula
C36H26N4
Molecular Weight
514.62
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhan W, et al. Discovery of small molecule CXCR4 antagonists. J Med Chem. 2007 Nov 15;50 (23) :5655-64.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items